Altesa raises $75M in Series B funding, led by Forbion and Sanofi, to develop antiviral drugs for COPD patients in a placebo-controlled phase IIb trial.
Amount Raised
$75 Million
Round Type
Series B
United StatesBiotechnologyHealth CareTherapeuticsInvestors
Description
Altesa secured $75 million in Series B financing to advance its antiviral drug development for COPD. The funding, which will support a phase IIb study in the US and UK, aims to evaluate the efficacy of vapendavir against rhinovirus infections. Notable investors include Sanofi, Forbion, Medicxi, and Pitango. This funding positions Altesa to target a niche within the competitive COPD market.
Quick answer
Altesa raised $75 Million in a Series B round, dated February 19, 2026. Investors: Medicxi, Pitango, Forbion and Sanofi. Altesa is based in United States.
- How much did Altesa raise?
- Altesa raised $75 Million in a Series B round on February 19, 2026.
- Who invested in Altesa?
- Medicxi, Pitango, Forbion and Sanofi are named as investors in this round.
- What does Altesa do?
- Altesa is a biotech company focused on developing antiviral drugs targeting common respiratory viruses, particularly for patients with chronic obstructive pulmonary disease (COPD).
- Where is Altesa based and how big is it?
- Altesa is based in United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Altesa that raised within 45 days of this round, from Fundz verified event records.
- Sonire Therapeutics raised $18M (Series A) on March 31, 2026.
- TippingPoint Biosciences raised $4.5M (Seed) on March 31, 2026.
- Denali Therapeutics raised $200M (Debt Financing) on March 31, 2026.
- Oncomatryx Biopharma raised $67M (Corporate Round) on March 30, 2026.
- Marvel Biosciences raised $476K (Grant) on March 30, 2026.
- Cellbricks Therapeutics raised $8.1M (Seed) on March 26, 2026.
Who to call at Altesa, and when
A new round usually means Altesa is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Altesa raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Altesa, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Altesa. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Altesa raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansAltesa raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.